TY  - BOOK
AU  - Reddy, Uma M
TI  - Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation
SN  - 0029-7844
PY  - 2017///
KW  - *Neonatal Abstinence Syndrome/pc [Prevention & Control]
KW  - *Opioid-Related Disorders/pc [Prevention & Control]
KW  - *Pregnancy Complications/pc [Prevention & Control]
KW  - Child
KW  - Child of Impaired Parents
KW  - Female
KW  - Humans
KW  - Infant, Newborn
KW  - Obstetrics
KW  - Pregnancy
KW  - Pregnancy Outcome
KW  - United States
KW  - MedStar Washington Hospital Center
KW  - Obstetrics and Gynecology, Maternal-Fetal Medicine
KW  - Consensus Development Conference
KW  - Journal Article
KW  - Practice Guideline
N1  - Available online from MWHC library: 1995 - present, Available in print through MWHC library: 1999 - 2006
N2  - In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human Development invited experts to a workshop to address numerous knowledge gaps and to review the evidence for the screening and management of opioid use in pregnancy and neonatal abstinence syndrome. The rising prevalence of opioid use in pregnancy has led to a concomitant dramatic fivefold increase in neonatal abstinence syndrome over the past decade. Experts from diverse disciplines addressed research gaps in the following areas: 1) optimal screening for opioid use in pregnancy; 2) complications of pregnancy associated with opioid use; 3) appropriate treatments for pregnant women with opioid use disorders; 4) the best approaches for detecting, treating, and managing newborns with neonatal abstinence syndrome; and 5) the long-term effects of prenatal opioid exposure on children. Workshop participants identified key scientific opportunities to advance the understanding of opioid use disorders in pregnancy and to improve outcomes for affected women, their children, and their families. This article provides a summary of the workshop presentations and discussions
UR  - https://dx.doi.org/10.1097/AOG.0000000000002054
ER  -